Federal contract award
75F40124C00132
CHARACTERIZING ALBUMIN-BOUND NANOPARTICLE DRUGS USING WNMR
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 334516 — Analytical Laboratory Instrument Manufacturing |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $460.0K |
| Current contract value | $460.0K |
| Potential contract value / ceiling | $460.0K |
| Start date | Sep 12, 2024 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 29, 2026 |
| Latest award activity | Feb 20, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 20, 2026 | P00003 | $0 | THIS IS AN ADMINISTRATIVE MODIFICATION TO UPDATE THE BUYER IN THE BACKEND OF THE PRISM CONTRACTING SYSTEM. NO CHANGES ARE CURRENTLY BEING MADE TO THE CONTRACT. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Feb 13, 2026 | P00002 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO CHANGE THE FDA SUPPLIER NUMBER FROM 283373 TO 1108634. ALL OTHER TERMS AND CONDITIONS OF THIS CONTRACT REMAIN UNCHANGED. |
| Aug 14, 2025 | P00001 | $200.0K | CHARACTERIZING ALBUMIN-BOUND NANOPARTICLE DRUGS USING WNMR |
| Sep 12, 2024 | 0 | $260.0K | CHARACTERIZING ALBUMIN-BOUND NANOPARTICLE DRUGS USING WNMR |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.